{
  "DOI": "10.1038/s41431-021-00920-y",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/s41431-021-00920-y",
  "alternative-id": [
    "920"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "12 January 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Revised",
      "name": "revised",
      "order": 2,
      "value": "28 May 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 3,
      "value": "4 June 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 4,
      "value": "15 July 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Date",
      "name": "change_date",
      "order": 5,
      "value": "27 September 2021"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Type",
      "name": "change_type",
      "order": 6,
      "value": "Correction"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Details",
      "name": "change_details",
      "order": 7,
      "value": "A Correction to this paper has been published:"
    },
    {
      "URL": "https://doi.org/10.1038/s41431-021-00969-9",
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Change Details",
      "name": "change_details",
      "order": 8,
      "value": "https://doi.org/10.1038/s41431-021-00969-9"
    },
    {
      "group": {
        "label": "COMPETING INTERESTS",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1,
      "value": "The authors declare no competing interests."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Matic",
      "given": "Maja",
      "sequence": "first"
    },
    {
      "ORCID": "http://orcid.org/0000-0001-7476-6867",
      "affiliation": [],
      "authenticated-orcid": false,
      "family": "Nijenhuis",
      "given": "Marga",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Soree",
      "given": "Bianca",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "de Boer-Veger",
      "given": "Nienke J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Buunk",
      "given": "Anne-Marie",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Houwink",
      "given": "Elisa J. F.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Mulder",
      "given": "Hans",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Rongen",
      "given": "Gerard A. P. J. M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Weide",
      "given": "Jan van der",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Wilffert",
      "given": "Bob",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Swen",
      "given": "Jesse J.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Guchelaar",
      "given": "Henk-Jan",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Deneer",
      "given": "Vera H. M.",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "van Schaik",
      "given": "Ron H. N.",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2021,
        7,
        15
      ]
    ],
    "date-time": "2021-07-15T08:02:52Z",
    "timestamp": 1626336172000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        10,
        11
      ]
    ],
    "date-time": "2022-10-11T15:03:49Z",
    "timestamp": 1665500629000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        5
      ]
    ],
    "date-time": "2024-04-05T08:29:54Z",
    "timestamp": 1712305794665
  },
  "is-referenced-by-count": 19,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "10",
  "issued": {
    "date-parts": [
      [
        2021,
        7,
        15
      ]
    ]
  },
  "journal-issue": {
    "issue": "10",
    "published-print": {
      "date-parts": [
        [
          2022,
          10
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            7,
            15
          ]
        ],
        "date-time": "2021-07-15T00:00:00Z",
        "timestamp": 1626307200000
      }
    },
    {
      "URL": "https://www.springer.com/tdm",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2021,
            7,
            15
          ]
        ],
        "date-time": "2021-07-15T00:00:00Z",
        "timestamp": 1626307200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://www.nature.com/articles/s41431-021-00920-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-021-00920-y",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://www.nature.com/articles/s41431-021-00920-y.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "1105-1113",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2021,
        7,
        15
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2021,
        7,
        15
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        10
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/sj.clpt.6100507",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "781",
      "journal-title": "Clin Pharm Ther",
      "key": "920_CR1",
      "unstructured": "Swen JJ, Wilting I, de Goede AL, Grandia L, Mulder H, Touw DJ, et al. Pharmacogenetics: from bench to byte. Clin Pharm Ther. 2008;83:781–7.",
      "volume": "83",
      "year": "2008"
    },
    {
      "DOI": "10.1038/s41431-018-0205-4",
      "author": "HJ Guchelaar",
      "doi-asserted-by": "publisher",
      "first-page": "1399",
      "journal-title": "J Hum Genet Eur J Hum Genet",
      "key": "920_CR2",
      "unstructured": "Guchelaar HJ. Pharmacogenomics, a novel section in the European. J Hum Genet Eur J Hum Genet. 2018;26:1399–400.",
      "volume": "26",
      "year": "2018"
    },
    {
      "key": "920_CR3",
      "unstructured": "Paineurope. WHO analgesic ladder (2018). http://www.paineurope.com/tools/who-analgesic-ladder. Accessed Oct 2017."
    },
    {
      "key": "920_CR4",
      "unstructured": "European Medicines Agency. Restrictions on use of codeine for pain relief in children—CMDh endorses PRAC recommendation (2018). http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Codeine_containing_medicinal_products/Position_provided_by_CMDh/WC500144850.pdf. Accessed Jun 2013."
    },
    {
      "DOI": "10.1038/clpt.2012.96",
      "author": "M Whirl-Carrillo",
      "doi-asserted-by": "publisher",
      "first-page": "414",
      "journal-title": "Clin Pharm Ther",
      "key": "920_CR5",
      "unstructured": "Whirl-Carrillo M, McDonagh EM, Hebert JM, Gong L, Sangkuhl K, Thorn CF, et al. Pharmacogenomics knowledge for personalized medicine. Clin Pharm Ther. 2012;92:414–7.",
      "volume": "92",
      "year": "2012"
    },
    {
      "DOI": "10.1097/FPC.0b013e32832e0eac",
      "author": "CF Thorn",
      "doi-asserted-by": "publisher",
      "first-page": "556",
      "journal-title": "Pharmacogenet Genom",
      "key": "920_CR6",
      "unstructured": "Thorn CF, Klein TE, Altman RB. Codeine and morphine pathway. Pharmacogenet Genom. 2009;19:556–8.",
      "volume": "19",
      "year": "2009"
    },
    {
      "DOI": "10.1097/FPC.0000000000000057",
      "author": "L Gong",
      "doi-asserted-by": "publisher",
      "first-page": "374",
      "journal-title": "Pharmacogenet Genom",
      "key": "920_CR7",
      "unstructured": "Gong L, Stamer UM, Tzvetkov MV, Altman RB, Klein TE. PharmGKB summary: tramadol pathway. Pharmacogenet Genom. 2014;24:374–80.",
      "volume": "24",
      "year": "2014"
    },
    {
      "DOI": "10.1097/FPC.0000000000000351",
      "author": "R Huddart",
      "doi-asserted-by": "publisher",
      "first-page": "230",
      "journal-title": "Pharmacogenet Genom",
      "key": "920_CR8",
      "unstructured": "Huddart R, Clarke M, Altman RB, Klein TE. PharmGKB summary: oxycodone pathway, pharmacokinetics. Pharmacogenet Genom. 2018;28:230–7.",
      "volume": "28",
      "year": "2018"
    },
    {
      "key": "920_CR9",
      "unstructured": "National Center for Biotechnology Information. CYP2D6 cytochrome P450 family 2 subfamily D member 6 [Homo sapiens (human)] (2018). https://www.ncbi.nlm.nih.gov/gene/1565. Accessed 4 Mar 2018."
    },
    {
      "key": "920_CR10",
      "unstructured": "gnomAD browser beta. Gene: CYP2D6. (2018). http://gnomad.broadinstitute.org/gene/ENSG00000100197."
    },
    {
      "key": "920_CR11",
      "unstructured": "Pharmacogene Variation Consortium. CYP2D6 allele nomenclature (2020). https://www.pharmvar.org/gene/CYP2D6."
    },
    {
      "DOI": "10.1002/cpt.690",
      "author": "Y Zhou",
      "doi-asserted-by": "publisher",
      "first-page": "688",
      "journal-title": "Clin Pharm Ther",
      "key": "920_CR12",
      "unstructured": "Zhou Y, Ingelman-Sundberg M, Lauschke VM. Worldwide distribution of Cytochrome P450 alleles: a meta-analysis of Population-scale Sequencing Projects. Clin Pharm Ther. 2017;102:688–700.",
      "volume": "102",
      "year": "2017"
    },
    {
      "DOI": "10.1007/s00228-006-0250-8",
      "author": "D Frank",
      "doi-asserted-by": "publisher",
      "first-page": "321",
      "journal-title": "Eur J Clin Pharm",
      "key": "920_CR13",
      "unstructured": "Frank D, Jaehde U, Fuhr U. Evaluation of probe drugs and pharmacokinetic metrics for CYP2D6 phenotyping. Eur J Clin Pharm. 2007;63:321–33.",
      "volume": "63",
      "year": "2007"
    },
    {
      "DOI": "10.1007/s40262-019-00783-z",
      "author": "G Magliocco",
      "doi-asserted-by": "publisher",
      "first-page": "1373",
      "journal-title": "Clin Pharmacokinet",
      "key": "920_CR14",
      "unstructured": "Magliocco G, Thomas A, Desmeules J, Daali Y. Phenotyping of human CYP450 enzymes by endobiotics: current knowledge and methodological approaches. Clin Pharmacokinet 2019;58:1373–91.",
      "volume": "58",
      "year": "2019"
    },
    {
      "DOI": "10.1038/clpt.1990.212",
      "author": "SH Sindrup",
      "doi-asserted-by": "publisher",
      "first-page": "686",
      "journal-title": "Clin Pharm Ther",
      "key": "920_CR15",
      "unstructured": "Sindrup SH, Brosen K, Bjerring P, Arendt-Nielsen L, Larsen U, Angelo HR, et al. Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine. Clin Pharm Ther. 1990;48:686–93.",
      "volume": "48",
      "year": "1990"
    },
    {
      "DOI": "10.1007/BF00280101",
      "author": "J Desmeules",
      "doi-asserted-by": "publisher",
      "first-page": "23",
      "journal-title": "Eur J Clin Pharm",
      "key": "920_CR16",
      "unstructured": "Desmeules J, Gascon MP, Dayer P, Magistris M. Impact of environmental and genetic factors on codeine analgesia. Eur J Clin Pharm. 1991;41:23–6.",
      "volume": "41",
      "year": "1991"
    },
    {
      "DOI": "10.1007/s002280050200",
      "author": "L Poulsen",
      "doi-asserted-by": "publisher",
      "first-page": "289",
      "journal-title": "Eur J Clin Pharm",
      "key": "920_CR17",
      "unstructured": "Poulsen L, Brosen K, Arendt-Nielsen L, Gram LF, Elbaek K, Sindrup SH. Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects. Eur J Clin Pharm. 1996;51:289–95.",
      "volume": "51",
      "year": "1996"
    },
    {
      "DOI": "10.1016/S0304-3959(98)00021-9",
      "author": "K Eckhardt",
      "doi-asserted-by": "publisher",
      "first-page": "27",
      "journal-title": "Pain",
      "key": "920_CR18",
      "unstructured": "Eckhardt K, Li S, Ammon S, Schanzle G, Mikus G, Eichelbaum M. Same incidence of adverse drug events after codeine administration irrespective of the genetically determined differences in morphine formation. Pain. 1998;76:27–33.",
      "volume": "76",
      "year": "1998"
    },
    {
      "DOI": "10.1097/FTD.0b013e3182272b10",
      "author": "S VanderVaart",
      "doi-asserted-by": "publisher",
      "first-page": "425",
      "journal-title": "Ther Drug Monit",
      "key": "920_CR19",
      "unstructured": "VanderVaart S, Berger H, Sistonen J, Madadi P, Matok I, Gijsen VM, et al. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study. Ther Drug Monit. 2011;33:425–32.",
      "volume": "33",
      "year": "2011"
    },
    {
      "DOI": "10.1093/bja/aef284",
      "author": "DG Williams",
      "doi-asserted-by": "publisher",
      "first-page": "839",
      "journal-title": "Br J Anaesth",
      "key": "920_CR20",
      "unstructured": "Williams DG, Patel A, Howard RF. Pharmacogenetics of codeine metabolism in an urban population of children and its implications for analgesic reliability. Br J Anaesth. 2002;89:839–45.",
      "volume": "89",
      "year": "2002"
    },
    {
      "DOI": "10.1371/journal.pone.0070073",
      "author": "LE Kelly",
      "doi-asserted-by": "publisher",
      "first-page": "e70073",
      "journal-title": "PLoS ONE",
      "key": "920_CR21",
      "unstructured": "Kelly LE, Chaudhry SA, Rieder MJ, t Jong G, Moretti ME, Lausman A, et al. A clinical tool for reducing central nervous system depression among neonates exposed to codeine through breast milk. PLoS ONE. 2013;8:e70073.",
      "volume": "8",
      "year": "2013"
    },
    {
      "DOI": "10.1038/tpj.2015.3",
      "author": "M Baber",
      "doi-asserted-by": "publisher",
      "first-page": "430",
      "journal-title": "Pharmacogenom J",
      "key": "920_CR22",
      "unstructured": "Baber M, Chaudhry S, Kelly L, Ross C, Carleton B, Berger H, et al. The pharmacogenetics of codeine pain relief in the postpartum period. Pharmacogenom J. 2015;15:430–5.",
      "volume": "15",
      "year": "2015"
    },
    {
      "DOI": "10.1038/clpt.2011.280",
      "author": "J Sistonen",
      "doi-asserted-by": "publisher",
      "first-page": "692",
      "journal-title": "Clin Pharm Ther",
      "key": "920_CR23",
      "unstructured": "Sistonen J, Madadi P, Ross CJ, Yazdanpanah M, Lee JW, Landsmeer ML, et al. Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers. Clin Pharm Ther. 2012;91:692–9.",
      "volume": "91",
      "year": "2012"
    },
    {
      "DOI": "10.1016/S0140-6736(06)69255-6",
      "author": "G Koren",
      "doi-asserted-by": "publisher",
      "first-page": "704",
      "journal-title": "Lancet",
      "key": "920_CR24",
      "unstructured": "Koren G, Cairns J, Chitayat D, Gaedigk A, Leeder SJ. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet. 2006;368:704.",
      "volume": "368",
      "year": "2006"
    },
    {
      "DOI": "10.1038/clpt.2008.157",
      "author": "P Madadi",
      "doi-asserted-by": "publisher",
      "first-page": "31",
      "journal-title": "Clin Pharm Ther",
      "key": "920_CR25",
      "unstructured": "Madadi P, Ross CJ, Hayden MR, Carleton BC, Gaedigk A, Leeder JS, et al. Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study. Clin Pharm Ther. 2009;85:31–5.",
      "volume": "85",
      "year": "2009"
    },
    {
      "DOI": "10.1056/NEJMc0904266",
      "author": "C Ciszkowski",
      "doi-asserted-by": "publisher",
      "first-page": "827",
      "journal-title": "N Engl J Med",
      "key": "920_CR26",
      "unstructured": "Ciszkowski C, Madadi P, Phillips MS, Lauwers AE, Koren G. Codeine, ultrarapid-metabolism genotype, and postoperative death. N Engl J Med. 2009;361:827–8.",
      "volume": "361",
      "year": "2009"
    },
    {
      "DOI": "10.1542/peds.2011-2538",
      "author": "LE Kelly",
      "doi-asserted-by": "publisher",
      "first-page": "e1343",
      "journal-title": "Pediatrics",
      "key": "920_CR27",
      "unstructured": "Kelly LE, Rieder M, van den Anker J, Malkin B, Ross C, Neely MN, et al. More codeine fatalities after tonsillectomy in North American children. Pediatrics. 2012;129:e1343–7.",
      "volume": "129",
      "year": "2012"
    },
    {
      "DOI": "10.1097/00007691-199710000-00011",
      "author": "P Dalen",
      "doi-asserted-by": "publisher",
      "first-page": "543",
      "journal-title": "Ther Drug Monit",
      "key": "920_CR28",
      "unstructured": "Dalen P, Frengell C, Dahl ML, Sjoqvist F. Quick onset of severe abdominal pain after codeine in an ultrarapid metabolizer of debrisoquine. Ther Drug Monit. 1997;19:543–4.",
      "volume": "19",
      "year": "1997"
    },
    {
      "DOI": "10.1056/NEJMoa041888",
      "author": "Y Gasche",
      "doi-asserted-by": "publisher",
      "first-page": "2827",
      "journal-title": "N Engl J Med",
      "key": "920_CR29",
      "unstructured": "Gasche Y, Daali Y, Fathi M, Chiappe A, Cottini S, Dayer P, et al. Codeine intoxication associated with ultrarapid CYP2D6 metabolism. N Engl J Med. 2004;351:2827–31.",
      "volume": "351",
      "year": "2004"
    },
    {
      "key": "920_CR30",
      "unstructured": "Electronic Medicines Compendium. Codeine phosphate 15 mg tablets (2018). https://www.medicines.org.uk/emc/product/7030. Accessed Mar 2017."
    },
    {
      "DOI": "10.1016/S0009-9236(96)90211-8",
      "author": "L Poulsen",
      "doi-asserted-by": "publisher",
      "first-page": "636",
      "journal-title": "Clin Pharm Ther",
      "key": "920_CR31",
      "unstructured": "Poulsen L, Arendt-Nielsen L, Brosen K, Sindrup SH. The hypoalgesic effect of tramadol in relation to CYP2D6. Clin Pharm Ther. 1996;60:636–44.",
      "volume": "60",
      "year": "1996"
    },
    {
      "DOI": "10.1007/s00228-005-0920-y",
      "author": "F Fliegert",
      "doi-asserted-by": "publisher",
      "first-page": "257",
      "journal-title": "Eur J Clin Pharm",
      "key": "920_CR32",
      "unstructured": "Fliegert F, Kurth B, Gohler K. The effects of tramadol on static and dynamic pupillometry in healthy subjects-the relationship between pharmacodynamics, pharmacokinetics and CYP2D6 metaboliser status. Eur J Clin Pharm. 2005;61:257–66.",
      "volume": "61",
      "year": "2005"
    },
    {
      "DOI": "10.1111/j.1365-2710.2010.01203.x",
      "author": "O Matouskova",
      "doi-asserted-by": "publisher",
      "first-page": "513",
      "journal-title": "J Clin Pharm Ther",
      "key": "920_CR33",
      "unstructured": "Matouskova O, Slanar O, Chytil L, Perlik F. Pupillometry in healthy volunteers as a biomarker of tramadol efficacy. J Clin Pharm Ther. 2011;36:513–7.",
      "volume": "36",
      "year": "2011"
    },
    {
      "DOI": "10.1016/S0304-3959(03)00212-4",
      "author": "UM Stamer",
      "doi-asserted-by": "publisher",
      "first-page": "231",
      "journal-title": "Pain",
      "key": "920_CR34",
      "unstructured": "Stamer UM, Lehnen K, Hothker F, Bayerer B, Wolf S, Hoeft A, et al. Impact of CYP2D6 genotype on postoperative tramadol analgesia. Pain. 2003;105:231–8.",
      "volume": "105",
      "year": "2003"
    },
    {
      "DOI": "10.1213/ane.0b013e31817b796e",
      "author": "UM Stamer",
      "doi-asserted-by": "publisher",
      "first-page": "926",
      "journal-title": "Anesth Analg",
      "key": "920_CR35",
      "unstructured": "Stamer UM, Stuber F, Muders T, Musshoff F. Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication. Anesth Analg. 2008;107:926–9.",
      "volume": "107",
      "year": "2008"
    },
    {
      "DOI": "10.1542/peds.2014-2673",
      "author": "G Orliaguet",
      "doi-asserted-by": "publisher",
      "first-page": "e753",
      "journal-title": "Pediatrics",
      "key": "920_CR36",
      "unstructured": "Orliaguet G, Hamza J, Couloigner V, Denoyelle F, Loriot MA, Broly F, et al. A case of respiratory depression in a child with ultrarapid CYP2D6 metabolism after tramadol. Pediatrics. 2015;135:e753–5.",
      "volume": "135",
      "year": "2015"
    },
    {
      "DOI": "10.1111/j.1399-6576.2009.02104.x",
      "author": "ST Zwisler",
      "doi-asserted-by": "publisher",
      "first-page": "232",
      "journal-title": "Acta Anaesthesiol Scand",
      "key": "920_CR37",
      "unstructured": "Zwisler ST, Enggaard TP, Mikkelsen S, Brosen K, Sindrup SH. Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesia. Acta Anaesthesiol Scand. 2010;54:232–40.",
      "volume": "54",
      "year": "2010"
    },
    {
      "DOI": "10.1002/cpt.771",
      "author": "K Cajanus",
      "doi-asserted-by": "publisher",
      "first-page": "653",
      "journal-title": "Clin Pharmacol Ther",
      "key": "920_CR38",
      "unstructured": "Cajanus K, Neuvonen M, Koskela O, Kaunisto MA, Neuvonen PJ, Niemi M, et al. Analgesic plasma concentrations of oxycodone after surgery for breast cancer-which factors matter? Clin Pharmacol Ther. 2017;103:653–62.",
      "volume": "103",
      "year": "2017"
    },
    {
      "DOI": "10.1371/journal.pone.0060239",
      "author": "UM Stamer",
      "doi-asserted-by": "publisher",
      "first-page": "e60239",
      "journal-title": "PLoS ONE",
      "key": "920_CR39",
      "unstructured": "Stamer UM, Zhang L, Book M, Lehmann LE, Stuber F, Musshoff F. CYP2D6 genotype dependent oxycodone metabolism in postoperative patients. PLoS ONE. 2013;8:e60239.",
      "volume": "8",
      "year": "2013"
    },
    {
      "DOI": "10.1007/s00228-011-1093-5",
      "author": "TN Andreassen",
      "doi-asserted-by": "publisher",
      "first-page": "55",
      "journal-title": "Eur J Clin Pharm",
      "key": "920_CR40",
      "unstructured": "Andreassen TN, Eftedal I, Klepstad P, Davies A, Bjordal K, Lundstrom S, et al. Do CYP2D6 genotypes reflect oxycodone requirements for cancer patients treated for cancer pain? A cross-sectional multicentre study. Eur J Clin Pharm. 2012;68:55–64.",
      "volume": "68",
      "year": "2012"
    },
    {
      "DOI": "10.1097/FTD.0b013e318288f158",
      "author": "J Lam",
      "doi-asserted-by": "publisher",
      "first-page": "466",
      "journal-title": "Ther Drug Monit",
      "key": "920_CR41",
      "unstructured": "Lam J, Kelly L, Matok I, Ross CJ, Carleton BC, Hayden MR, et al. Putative association of ABCB1 2677G\u003eT/A with oxycodone-induced central nervous system depression in breastfeeding mothers. Ther Drug Monit. 2013;35:466–72.",
      "volume": "35",
      "year": "2013"
    },
    {
      "DOI": "10.1111/j.1476-5381.2010.00709.x",
      "author": "CF Samer",
      "doi-asserted-by": "publisher",
      "first-page": "919",
      "journal-title": "Br J Pharm",
      "key": "920_CR42",
      "unstructured": "Samer CF, Daali Y, Wagner M, Hopfgartner G, Eap CB, Rebsamen MC, et al. Genetic polymorphisms and drug interactions modulating CYP2D6 and CYP3A activities have a major effect on oxycodone analgesic efficacy and safety. Br J Pharm. 2010;160:919–30.",
      "volume": "160",
      "year": "2010"
    },
    {
      "DOI": "10.1111/j.1742-7843.2009.00378.x",
      "author": "ST Zwisler",
      "doi-asserted-by": "publisher",
      "first-page": "335",
      "journal-title": "Basic Clin Pharm Toxicol",
      "key": "920_CR43",
      "unstructured": "Zwisler ST, Enggaard TP, Noehr-Jensen L, Pedersen RS, Mikkelsen S, Nielsen F, et al. The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism. Basic Clin Pharm Toxicol. 2009;104:335–44.",
      "volume": "104",
      "year": "2009"
    },
    {
      "DOI": "10.1097/01.jcp.0000085421.74359.60",
      "author": "J de Leon",
      "doi-asserted-by": "publisher",
      "first-page": "420",
      "journal-title": "J Clin Psychopharmacol",
      "key": "920_CR44",
      "unstructured": "de Leon J, Dinsmore L, Wedlund P. Adverse drug reactions to oxycodone and hydrocodone in CYP2D6 ultrarapid metabolizers. J Clin Psychopharmacol. 2003;23:420–1.",
      "volume": "23",
      "year": "2003"
    },
    {
      "DOI": "10.1038/nrd3921",
      "author": "M Pirmohamed",
      "doi-asserted-by": "publisher",
      "first-page": "3",
      "journal-title": "Nat Rev Drug Discov",
      "key": "920_CR45",
      "unstructured": "Pirmohamed M, Hughes DA. Pharmacogenetic tests: the need for a level playing field. Nat Rev Drug Discov. 2013;12:3–4.",
      "volume": "12",
      "year": "2013"
    },
    {
      "DOI": "10.1371/journal.pmed.0040209",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "e209",
      "journal-title": "PLoS Med",
      "key": "920_CR46",
      "unstructured": "Swen JJ, Huizinga TW, Gelderblom H, de Vries EG, Assendelft WJ, Kirchheiner J, et al. Translating pharmacogenomics: challenges on the road to the clinic. PLoS Med. 2007;4:e209.",
      "volume": "4",
      "year": "2007"
    },
    {
      "DOI": "10.1002/cpt.1049",
      "author": "JJ Swen",
      "doi-asserted-by": "publisher",
      "first-page": "795",
      "journal-title": "Clin Pharm Ther",
      "key": "920_CR47",
      "unstructured": "Swen JJ, Nijenhuis M, van Rhenen M, de Boer-Veger NJ, Buunk AM, Houwink EJF, et al. Pharmacogenetic information in clinical guidelines: the European Perspective. Clin Pharm Ther. 2018;103:795–801.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1038/clpt.2013.254",
      "author": "KR Crews",
      "doi-asserted-by": "publisher",
      "first-page": "376",
      "journal-title": "Clin Pharm Ther",
      "key": "920_CR48",
      "unstructured": "Crews KR, Gaedigk A, Dunnenberger HM, Leeder JS, Klein TE, Caudle KE, et al. Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. Clin Pharm Ther. 2014;95:376–82.",
      "volume": "95",
      "year": "2014"
    },
    {
      "author": "P Madadi",
      "first-page": "e369",
      "journal-title": "J Popul Ther Clin Pharm",
      "key": "920_CR49",
      "unstructured": "Madadi P, Amstutz U, Rieder M, Ito S, Fung V, Hwang S, et al. Clinical practice guideline: CYP2D6 genotyping for safe and efficacious codeine therapy. J Popul Ther Clin Pharm. 2013;20:e369–96.",
      "volume": "20",
      "year": "2013"
    },
    {
      "DOI": "10.1002/cpt.762",
      "author": "PCD Bank",
      "doi-asserted-by": "publisher",
      "first-page": "599",
      "journal-title": "Clin Pharm Ther",
      "key": "920_CR50",
      "unstructured": "Bank PCD, Caudle KE, Swen JJ, Gammal RS, Whirl-Carrillo M, Klein TE, et al. Comparison of the guidelines of the clinical pharmacogenetics implementation Consortium and the Dutch Pharmacogenetics Working Group. Clin Pharm Ther. 2018;103:599–618.",
      "volume": "103",
      "year": "2018"
    },
    {
      "DOI": "10.1002/cpt.2149",
      "doi-asserted-by": "publisher",
      "key": "920_CR51",
      "unstructured": "Crews KR, Monte AA, Huddart R, Caudle KE, Kharasch ED, Gaedigk A, et al. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT genotypes and select opioid therapy. Clin Pharmacol Ther. 2021. https://doi.org/10.1002/cpt.2149."
    }
  ],
  "reference-count": 51,
  "references-count": 51,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/s41431-021-00920-y"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone)"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "30"
}